Meeder Advisory Services Inc. acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,859 shares of the semiconductor company's stock, valued at approximately $2,167,000.
Several other large investors have also bought and sold shares of SNPS. Sankala Group LLC acquired a new position in Synopsys during the 4th quarter worth about $25,000. Elevation Wealth Partners LLC increased its stake in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after buying an additional 27 shares during the period. IMG Wealth Management Inc. bought a new position in shares of Synopsys during the second quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Synopsys during the fourth quarter worth about $28,000. Finally, Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the fourth quarter worth approximately $32,000. 85.47% of the stock is owned by institutional investors.
Insider Buying and Selling at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company's stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
SNPS has been the topic of several analyst reports. Citigroup upped their target price on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Piper Sandler upgraded shares of Synopsys from a "neutral" rating to an "overweight" rating and boosted their price target for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research note on Wednesday, May 27th. Rosenblatt Securities increased their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a research report on Tuesday, May 26th. Finally, Wells Fargo & Company decreased their price objective on shares of Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $565.06.
View Our Latest Analysis on Synopsys
Synopsys Trading Down 2.1%
NASDAQ SNPS opened at $404.41 on Wednesday. The business has a 50 day simple moving average of $423.21 and a 200 day simple moving average of $441.54. Synopsys, Inc. has a one year low of $366.00 and a one year high of $624.82. The stock has a market capitalization of $77.44 billion, a P/E ratio of 93.61, a P/E/G ratio of 2.48 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same period in the previous year, the firm earned $3.67 earnings per share. The company's revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.